RTX (RTX) — Nuclear Contract & Q3 Strength

Executive Summary

Company Overview

RTX Corporation operates in the Aerospace & Defense industry, providing aircraft engines, defense systems, avionics, missile systems, and related services to government and commercial customers worldwide. The company combines legacy capabilities across multiple defense and civil aerospace franchises.

Key Products & Competitive Position

• Core Business: Aerospace propulsion, military systems, space and missile defense, commercial avionics and aftermarket services.
• Key Products: Jet engines, radar and missile systems, electronic warfare, and maintenance repair and overhaul services for commercial and military fleets.
• Competitive Moat: Large installed base, long-term service contracts, deep engineering expertise, and strategic relationships with national defense agencies.

Recent Developments

Heading into the long weekend markets, RTX reported a strong Q3 2026 result on October 20 with EPS of $2.26 versus an estimate of $1.78. On October 29 the board declared a quarterly cash dividend of $0.73 per share. On October 30 media reported that RTX won an approximate $8 billion contract related to U.S. nuclear forces modernization, which will add to the company backlog and revenue visibility over multiple years. These developments reinforce both cash return and backlog strength.

Financial Snapshot

Revenue & Earnings Trends

RTX's top-line has shown consistent recovery since 2022. Trailing twelve months revenue stands near $96.0 billion per recent data, up from about $88.6 billion in 2025. Earnings have rebounded strongly, with reported EPS growth noted at roughly 34 percent year over year in recent summaries. The last four reported quarters each beat consensus estimates, culminating in Q3 2026 EPS of $2.26, a 27 percent surprise versus the estimate of $1.78.

Balance Sheet Highlights

The balance sheet shows roughly $9.17 billion in cash and equivalents against total debt of about $38.87 billion. That implies net debt but remains consistent with capital intensity in aerospace and defense. The current ratio is around 1.05, indicating minimal working capital cushion, while the quick ratio near 0.67 suggests inventory and contract assets play a meaningful role in short-term liquidity. Debt to equity stands near 55 percent according to available data.

Valuation Analysis

Historical Comparison

Trailing P/E near 32 compares to a forward P/E near 24.8, reflecting analysts applying earnings growth to compress the multiple. Over the past five years RTX has traded through a range of valuation multiples as defense cycles and commercial aerospace recovery have played out. Current multiples sit modestly above historical averages for the company in lower-growth periods, but below pandemic-era volatility highs.

Fair Value Estimate

Using consensus forward earnings and a blended multiple near 24 to 26 yields a fair value range roughly in the low to mid $230s per share. That aligns with the analyst mean target near $232. Given a dividend yield around 1.4 percent and continued margin improvement, fair value can be framed between $220 and $245, conditional on delivery of backlog and stable defense budgets.

Competitive Landscape

Key Competitors

Competitive Advantages

• Moat 1: Long-term service contracts and installed base provide recurring aftermarket revenue.
• Moat 2: Deep engineering and program management capabilities for complex defense projects.
• Moat 3: Scale in procurement and production that supports margin resilience across business cycles.

Earnings Track Record

Recent Earnings History

Guidance Trend

Management has signaled improved margin cadence and growing aftermarket services contribution. Analysts are modeling elevated free cash flow and steady margin improvement into 2027, which is reflected in a forward P/E materially below the trailing multiple. The next expected report is January 26, 2027 with a consensus EPS estimate for the quarter near $1.83.

Analyst Sentiment

Price Targets

• Low: $208
• Mean: $232.18 (+16.2% upside)
• High: $250

Recent Analyst Actions

Analysts have adjusted models upward after the recent string of quarterly beats and the addition of the multi-year nuclear contract. The consensus tilt toward Strong Buy reflects higher confidence in near-term earnings and sustained aftermarket revenue growth.

Recent News & Catalysts

Key Developments

• $8B Nuclear Contract (10/30/2026): Media reports indicate RTX secured a roughly $8 billion contract related to U.S. nuclear modernization efforts, which should increase backlog and multi-year revenue visibility.
• Dividend Declared (10/29/2026): The board declared a quarterly cash dividend of $0.73 per share, reinforcing cash return policy and showing balance sheet confidence.
• Q3 2026 Beat (10/20/2026): EPS of $2.26 beat the $1.78 estimate, continuing a streak of quarterly beats and prompting upward analyst revisions.

Upcoming Catalysts

Technical Outlook

Trend Analysis

Price action since the 52-week high shows a consolidation pattern with support near the $166 to $175 band during the prior low. The recent earnings beat and contract news have supported stability above $195. RTX's low beta of 0.31 signals that the stock has historically tracked defensive characteristics versus the broad market, which investors often expect in large defense primes.

Key Levels

• Resistance: $210, $226.88
• Support: $190, $166.74

Bull vs Bear Case

Risks to Consider

Bottom Line

Action Items for Investors

• Long-term investors: Track backlog conversion and free cash flow trends, and monitor the integration and ramp schedule for the nuclear contract to assess mid-term earnings durability.
• Short-term traders: Watch technical levels at $190 and $210, earnings commentary on January 26, 2027, and any government disclosures about contract timing that could move sentiment.
• Risk management: Consider position sizing relative to diversification, set clear stop rules, and use the dividend and cash flow metrics to evaluate downside support.

What to Watch This Week

• Any follow-up reporting or official filings clarifying scope and timing of the reported $8 billion nuclear contract.
• Analyst note revisions and updated price targets after the Oct 29 dividend and Oct 30 contract news.
• Macro headlines that could affect commercial aerospace demand and aftermarket volume.